Rosenbaum Jay D. increased its stake in Danaher Corporation (NYSE:DHR) by 10.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,400 shares of the conglomerate’s stock after buying an additional 405 shares during the period. Rosenbaum Jay D.’s holdings in Danaher Corporation were worth $371,000 as of its most recent filing with the SEC.
Several other hedge funds also recently made changes to their positions in the company. BlackRock Inc. increased its stake in shares of Danaher Corporation by 2,530.9% in the first quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock valued at $3,247,398,000 after buying an additional 36,524,795 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Danaher Corporation by 3.9% in the first quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock valued at $3,503,962,000 after buying an additional 1,530,015 shares during the last quarter. MARSHALL WACE ASIA Ltd bought a new stake in shares of Danaher Corporation during the first quarter valued at approximately $116,462,000. Marshall Wace North America L.P. bought a new stake in shares of Danaher Corporation during the first quarter valued at approximately $116,462,000. Finally, Parnassus Investments CA increased its stake in shares of Danaher Corporation by 15.3% in the first quarter. Parnassus Investments CA now owns 8,622,528 shares of the conglomerate’s stock valued at $712,738,000 after buying an additional 1,143,284 shares during the last quarter. 76.56% of the stock is owned by institutional investors and hedge funds.
Shares of Danaher Corporation (NYSE:DHR) traded up 0.67% during trading on Friday, hitting $79.82. 2,433,944 shares of the stock traded hands. The company has a market cap of $55.45 billion, a P/E ratio of 25.48 and a beta of 1.03. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.01. The stock has a 50-day moving average of $82.89 and a 200 day moving average of $84.21.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 EPS for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. During the same period last year, the business earned $0.90 earnings per share. Danaher Corporation’s revenue was up 6.3% compared to the same quarter last year. On average, equities research analysts predict that Danaher Corporation will post $3.95 EPS for the current fiscal year.
Several analysts recently commented on DHR shares. Janney Montgomery Scott downgraded shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a report on Wednesday, June 7th. BidaskClub downgraded shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Saturday, July 8th. Wells Fargo & Company reissued a “market perform” rating on shares of Danaher Corporation in a report on Saturday, July 22nd. Cowen and Company reissued an “outperform” rating and issued a $90.00 price objective on shares of Danaher Corporation in a report on Sunday, April 23rd. Finally, William Blair reissued an “outperform” rating on shares of Danaher Corporation in a report on Sunday, April 23rd. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. Danaher Corporation currently has a consensus rating of “Buy” and an average target price of $91.76.
In other news, SVP Angela S. Lalor sold 10,815 shares of the firm’s stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total value of $910,190.40. Following the completion of the transaction, the senior vice president now directly owns 39,020 shares in the company, valued at $3,283,923.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the transaction, the insider now owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The disclosure for this sale can be found here. Insiders sold 38,623 shares of company stock valued at $3,206,426 over the last 90 days. 12.20% of the stock is owned by company insiders.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.